Aquestive Therapeutics, Inc. (AQST)
6.385
+0.16
(+2.49%)
USD |
NASDAQ |
Dec 11, 11:57
Aquestive Therapeutics Cash from Investing (Quarterly): -0.235M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 401.00M |
| Eli Lilly & Co. | -2.983B |
| Madrigal Pharmaceuticals, Inc. | -207.00M |
| TransCode Therapeutics, Inc. | 0.00 |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.65M |
| Cash from Financing (Quarterly) | 81.41M |
| Free Cash Flow | -50.94M |
| Free Cash Flow Per Share (Quarterly) | -0.1165 |
| Free Cash Flow to Equity (Quarterly) | -15.49M |
| Free Cash Flow to Firm (Quarterly) | -8.611M |
| Free Cash Flow Yield | -8.05% |